Suppression of HDAC3 and EZH2 cooperatively inhibited the MYC-EZH2-miR-29 axis, leading to reexpression of miR-29, therefore downregulating miR-29-targeted genes and inhibiting lymphoma progression [75]. Here, HDAC3 is linked to lymphoma.